Hainan Huluwa Pharmaceutical Group Co (SHSE:605199) Change In Payables And Accrued Expense : ¥0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Hainan Huluwa Pharmaceutical Group Co Change In Payables And Accrued Expense?

Hainan Huluwa Pharmaceutical Group Co's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2024 was ¥0 Mil. It means Hainan Huluwa Pharmaceutical Group Co's Accounts Payable & Accrued Expense stayed the same from Dec. 2023 to Mar. 2024 .

Hainan Huluwa Pharmaceutical Group Co's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was ¥0 Mil. It means Hainan Huluwa Pharmaceutical Group Co's Accounts Payable & Accrued Expense stayed the same from Dec. 2022 to Dec. 2023 .

Hainan Huluwa Pharmaceutical Group Co Change In Payables And Accrued Expense Historical Data

The historical data trend for Hainan Huluwa Pharmaceutical Group Co's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hainan Huluwa Pharmaceutical Group Co Change In Payables And Accrued Expense Chart

Hainan Huluwa Pharmaceutical Group Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

Hainan Huluwa Pharmaceutical Group Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

Hainan Huluwa Pharmaceutical Group Co Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Hainan Huluwa Pharmaceutical Group Co Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Hainan Huluwa Pharmaceutical Group Co's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Hainan Huluwa Pharmaceutical Group Co (SHSE:605199) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hainan Huluwa Pharmaceutical Group Co Ltd (SHSE:605199) » Definitions » Change In Payables And Accrued Expense

Traded in Other Exchanges

N/A

Address

No. 8, Yaogu 4th Road, Phase II, Yaogu Industrial Park, Haikou National High-tech Zone, Hainan Province, Haikou, CHN, 570300

Website

http://www.huluwayaoye.com

Hainan Huluwa Pharmaceutical Group Co Ltd is engaged in production and sales of Chinese patent medicines and chemical drugs. The company produces medicines for children's respiratory and digestive systems. Its products include star products, calabash, gourd dad, and gourd mom.

Hainan Huluwa Pharmaceutical Group Co (SHSE:605199) Headlines

No Headlines